nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—RYR1—kidney cancer	0.788	1	CbGaD
Suramin—F2—posterior vena cava—kidney cancer	0.0194	0.209	CbGeAlD
Suramin—F2—urine—kidney cancer	0.00502	0.0541	CbGeAlD
Suramin—P2RY2—renal system—kidney cancer	0.00454	0.0489	CbGeAlD
Suramin—P2RY2—kidney—kidney cancer	0.00439	0.0473	CbGeAlD
Suramin—FSHR—gonad—kidney cancer	0.00383	0.0413	CbGeAlD
Suramin—P2RX4—nephron tubule—kidney cancer	0.00292	0.0315	CbGeAlD
Suramin—SIRT5—renal system—kidney cancer	0.0028	0.0302	CbGeAlD
Suramin—SIRT5—kidney—kidney cancer	0.00271	0.0292	CbGeAlD
Suramin—P2RX4—renal system—kidney cancer	0.00265	0.0286	CbGeAlD
Suramin—SIRT5—cortex of kidney—kidney cancer	0.00264	0.0285	CbGeAlD
Suramin—P2RX4—kidney—kidney cancer	0.00256	0.0276	CbGeAlD
Suramin—SIRT1—nephron tubule—kidney cancer	0.00256	0.0276	CbGeAlD
Suramin—SIRT5—gonad—kidney cancer	0.00251	0.0271	CbGeAlD
Suramin—SIRT5—cardiac atrium—kidney cancer	0.00251	0.0271	CbGeAlD
Suramin—P2RX4—cortex of kidney—kidney cancer	0.0025	0.0269	CbGeAlD
Suramin—P2RX4—cardiac atrium—kidney cancer	0.00237	0.0256	CbGeAlD
Suramin—SIRT1—renal system—kidney cancer	0.00232	0.0251	CbGeAlD
Suramin—ARSA—renal system—kidney cancer	0.00229	0.0248	CbGeAlD
Suramin—SIRT1—kidney—kidney cancer	0.00225	0.0242	CbGeAlD
Suramin—ARSA—kidney—kidney cancer	0.00222	0.0239	CbGeAlD
Suramin—SIRT1—cortex of kidney—kidney cancer	0.00219	0.0236	CbGeAlD
Suramin—SIRT1—gonad—kidney cancer	0.00208	0.0225	CbGeAlD
Suramin—SIRT1—cardiac atrium—kidney cancer	0.00208	0.0224	CbGeAlD
Suramin—ARSA—gonad—kidney cancer	0.00206	0.0222	CbGeAlD
Suramin—PLA2G2A—renal system—kidney cancer	0.00163	0.0175	CbGeAlD
Suramin—PLA2G2A—kidney—kidney cancer	0.00157	0.017	CbGeAlD
Suramin—PLA2G2A—cardiac atrium—kidney cancer	0.00146	0.0157	CbGeAlD
Suramin—F2—renal system—kidney cancer	0.00123	0.0132	CbGeAlD
Suramin—F2—kidney—kidney cancer	0.00119	0.0128	CbGeAlD
Suramin—PLA2G4A—renal system—kidney cancer	0.00113	0.0122	CbGeAlD
Suramin—PLA2G4A—cortex of kidney—kidney cancer	0.00106	0.0115	CbGeAlD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—kidney cancer	3.01e-05	0.000252	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IGF2—kidney cancer	3.01e-05	0.000252	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HIF1A—kidney cancer	3e-05	0.000251	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TSC2—kidney cancer	2.99e-05	0.00025	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KDR—kidney cancer	2.97e-05	0.000248	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.95e-05	0.000247	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PGK1—kidney cancer	2.95e-05	0.000247	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SLC5A3—kidney cancer	2.95e-05	0.000247	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—LDHB—kidney cancer	2.89e-05	0.000242	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.88e-05	0.000241	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KDR—kidney cancer	2.87e-05	0.00024	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	2.86e-05	0.00024	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GPC3—kidney cancer	2.84e-05	0.000238	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CER1—kidney cancer	2.84e-05	0.000238	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ANXA1—kidney cancer	2.83e-05	0.000237	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ITPR2—kidney cancer	2.8e-05	0.000235	CbGpPWpGaD
Suramin—PLA2G4A—Phospholipid metabolism—PIK3CA—kidney cancer	2.78e-05	0.000233	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.75e-05	0.00023	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—APC—kidney cancer	2.73e-05	0.000229	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KIT—kidney cancer	2.73e-05	0.000229	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.7e-05	0.000226	CbGpPWpGaD
Suramin—ARSA—Metabolism—POMC—kidney cancer	2.68e-05	0.000224	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.67e-05	0.000224	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSTP1—kidney cancer	2.66e-05	0.000222	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SFRP2—kidney cancer	2.64e-05	0.000221	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—APC—kidney cancer	2.64e-05	0.000221	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KIT—kidney cancer	2.64e-05	0.000221	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—MAPK3—kidney cancer	2.62e-05	0.000219	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—POMC—kidney cancer	2.6e-05	0.000218	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.6e-05	0.000218	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	2.59e-05	0.000216	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGF2—kidney cancer	2.59e-05	0.000216	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—BRAF—kidney cancer	2.57e-05	0.000215	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ANXA1—kidney cancer	2.57e-05	0.000215	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.53e-05	0.000212	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—MAPK3—kidney cancer	2.53e-05	0.000212	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.53e-05	0.000212	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ABCB1—kidney cancer	2.52e-05	0.000211	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—POMC—kidney cancer	2.51e-05	0.00021	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CA9—kidney cancer	2.51e-05	0.00021	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—MAPK1—kidney cancer	2.49e-05	0.000208	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—BRAF—kidney cancer	2.48e-05	0.000208	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.47e-05	0.000207	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	2.46e-05	0.000206	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—POMC—kidney cancer	2.45e-05	0.000205	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.45e-05	0.000205	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.45e-05	0.000205	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSTM1—kidney cancer	2.44e-05	0.000204	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SFRP2—kidney cancer	2.42e-05	0.000202	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.41e-05	0.000201	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—MAPK1—kidney cancer	2.41e-05	0.000201	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—PIK3CA—kidney cancer	2.39e-05	0.0002	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—PIK3CA—kidney cancer	2.38e-05	0.000199	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—KRAS—kidney cancer	2.35e-05	0.000197	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ANXA1—kidney cancer	2.35e-05	0.000197	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.34e-05	0.000196	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.32e-05	0.000194	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP1A1—kidney cancer	2.32e-05	0.000194	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.31e-05	0.000194	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—PIK3CA—kidney cancer	2.3e-05	0.000192	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—KRAS—kidney cancer	2.27e-05	0.00019	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.2e-05	0.000184	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PIK3CA—kidney cancer	2.16e-05	0.000181	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.15e-05	0.00018	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RAF1—kidney cancer	2.15e-05	0.00018	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGS2—kidney cancer	2.14e-05	0.000179	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—RELA—kidney cancer	2.14e-05	0.000179	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	2.13e-05	0.000179	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CRABP1—kidney cancer	2.13e-05	0.000178	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CASP2—kidney cancer	2.13e-05	0.000178	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKAP13—kidney cancer	2.13e-05	0.000178	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ERBB2—kidney cancer	2.12e-05	0.000178	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MTOR—kidney cancer	2.09e-05	0.000175	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.09e-05	0.000175	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PIK3CA—kidney cancer	2.09e-05	0.000175	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.08e-05	0.000174	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RAF1—kidney cancer	2.07e-05	0.000173	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—RELA—kidney cancer	2.06e-05	0.000173	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ERBB2—kidney cancer	2.05e-05	0.000172	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MTOR—kidney cancer	2.02e-05	0.000169	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ITPR2—kidney cancer	1.98e-05	0.000166	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CDKN1B—kidney cancer	1.97e-05	0.000165	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKAP13—kidney cancer	1.95e-05	0.000163	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRB7—kidney cancer	1.95e-05	0.000163	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CASP2—kidney cancer	1.95e-05	0.000163	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL2—kidney cancer	1.92e-05	0.000161	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.91e-05	0.00016	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.9e-05	0.000159	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CDKN1B—kidney cancer	1.9e-05	0.000159	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCND1—kidney cancer	1.88e-05	0.000157	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—JUN—kidney cancer	1.87e-05	0.000157	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTEN—kidney cancer	1.86e-05	0.000156	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL2—kidney cancer	1.86e-05	0.000155	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CTNNB1—kidney cancer	1.86e-05	0.000155	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MAPK3—kidney cancer	1.84e-05	0.000154	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.83e-05	0.000153	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ITPR2—kidney cancer	1.81e-05	0.000152	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCND1—kidney cancer	1.81e-05	0.000152	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PTEN—kidney cancer	1.81e-05	0.000151	CbGpPWpGaD
Suramin—F2—Hemostasis—RAF1—kidney cancer	1.81e-05	0.000151	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—JUN—kidney cancer	1.81e-05	0.000151	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ACHE—kidney cancer	1.81e-05	0.000151	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTT1—kidney cancer	1.81e-05	0.000151	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CTNNB1—kidney cancer	1.79e-05	0.00015	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MYC—kidney cancer	1.79e-05	0.000149	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRB7—kidney cancer	1.78e-05	0.000149	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PTEN—kidney cancer	1.75e-05	0.000146	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—POMC—kidney cancer	1.73e-05	0.000144	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—POMC—kidney cancer	1.73e-05	0.000144	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SCARB1—kidney cancer	1.71e-05	0.000143	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS1—kidney cancer	1.69e-05	0.000142	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PSMD7—kidney cancer	1.66e-05	0.000139	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ITPR2—kidney cancer	1.66e-05	0.000139	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—RAF1—kidney cancer	1.65e-05	0.000138	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CTNNA1—kidney cancer	1.64e-05	0.000137	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—kidney cancer	1.63e-05	0.000137	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HSPB1—kidney cancer	1.63e-05	0.000137	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EIF4EBP1—kidney cancer	1.63e-05	0.000137	CbGpPWpGaD
Suramin—F2—Hemostasis—IL2—kidney cancer	1.62e-05	0.000136	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—kidney cancer	1.58e-05	0.000132	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—BCHE—kidney cancer	1.57e-05	0.000132	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SLC5A5—kidney cancer	1.55e-05	0.00013	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MAPK3—kidney cancer	1.55e-05	0.000129	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PSMD7—kidney cancer	1.52e-05	0.000127	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ANXA1—kidney cancer	1.52e-05	0.000127	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TSC1—kidney cancer	1.52e-05	0.000127	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MYC—kidney cancer	1.5e-05	0.000126	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CTNNA1—kidney cancer	1.5e-05	0.000126	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SLC2A1—kidney cancer	1.5e-05	0.000126	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MAPK3—kidney cancer	1.49e-05	0.000125	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HSPB1—kidney cancer	1.49e-05	0.000125	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EIF4EBP1—kidney cancer	1.49e-05	0.000125	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IL2—kidney cancer	1.48e-05	0.000124	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MAPK1—kidney cancer	1.47e-05	0.000123	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FLT1—kidney cancer	1.47e-05	0.000123	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.46e-05	0.000122	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MYC—kidney cancer	1.45e-05	0.000122	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MAPK1—kidney cancer	1.42e-05	0.000119	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KRAS—kidney cancer	1.39e-05	0.000116	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PSMD7—kidney cancer	1.39e-05	0.000116	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TSC1—kidney cancer	1.39e-05	0.000116	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ANXA1—kidney cancer	1.39e-05	0.000116	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—POMC—kidney cancer	1.39e-05	0.000116	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—kidney cancer	1.38e-05	0.000115	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—kidney cancer	1.38e-05	0.000115	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PAK1—kidney cancer	1.36e-05	0.000114	CbGpPWpGaD
Suramin—F2—Signaling Pathways—JUNB—kidney cancer	1.36e-05	0.000114	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FLT1—kidney cancer	1.34e-05	0.000113	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KRAS—kidney cancer	1.34e-05	0.000112	CbGpPWpGaD
Suramin—ARSA—Metabolism—PIK3CA—kidney cancer	1.31e-05	0.00011	CbGpPWpGaD
Suramin—F2—Hemostasis—MAPK3—kidney cancer	1.3e-05	0.000109	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PIK3CA—kidney cancer	1.28e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.27e-05	0.000106	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—kidney cancer	1.26e-05	0.000105	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—POMC—kidney cancer	1.26e-05	0.000105	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTP1—kidney cancer	1.25e-05	0.000105	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—JUNB—kidney cancer	1.25e-05	0.000104	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PAK1—kidney cancer	1.25e-05	0.000104	CbGpPWpGaD
Suramin—F2—Hemostasis—MAPK1—kidney cancer	1.24e-05	0.000104	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—kidney cancer	1.24e-05	0.000103	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PIK3CA—kidney cancer	1.23e-05	0.000103	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CTNNB1—kidney cancer	1.23e-05	0.000103	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTEN—kidney cancer	1.2e-05	0.0001	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—kidney cancer	1.19e-05	9.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—MAPK3—kidney cancer	1.19e-05	9.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ABCB1—kidney cancer	1.19e-05	9.92e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—KRAS—kidney cancer	1.17e-05	9.8e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—POMC—kidney cancer	1.15e-05	9.63e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTM1—kidney cancer	1.15e-05	9.63e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—MAPK1—kidney cancer	1.13e-05	9.49e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF2—kidney cancer	1.11e-05	9.32e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CDKN2B—kidney cancer	1.11e-05	9.28e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP1A1—kidney cancer	1.09e-05	9.13e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1R—kidney cancer	1.08e-05	9.01e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—PIK3CA—kidney cancer	1.08e-05	9.01e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—KRAS—kidney cancer	1.07e-05	8.97e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—kidney cancer	1.04e-05	8.71e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—RAF1—kidney cancer	1.04e-05	8.69e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—IL2—kidney cancer	1.02e-05	8.58e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF2—kidney cancer	1.02e-05	8.53e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CDKN2B—kidney cancer	1.01e-05	8.49e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1R—kidney cancer	9.85e-06	8.24e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PIK3CA—kidney cancer	9.84e-06	8.24e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—kidney cancer	9.52e-06	7.97e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—RAF1—kidney cancer	9.49e-06	7.94e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL2—kidney cancer	9.31e-06	7.79e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.96e-06	7.5e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HIF1A—kidney cancer	8.87e-06	7.42e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TSC2—kidney cancer	8.85e-06	7.4e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL2—kidney cancer	8.51e-06	7.12e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KDR—kidney cancer	8.48e-06	7.1e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3CA—kidney cancer	8.47e-06	7.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—POMC—kidney cancer	8.13e-06	6.81e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HIF1A—kidney cancer	8.11e-06	6.79e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TSC2—kidney cancer	8.09e-06	6.77e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KIT—kidney cancer	7.81e-06	6.54e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APC—kidney cancer	7.81e-06	6.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KDR—kidney cancer	7.76e-06	6.49e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MAPK3—kidney cancer	7.48e-06	6.26e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—POMC—kidney cancer	7.44e-06	6.22e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—BRAF—kidney cancer	7.34e-06	6.15e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KIT—kidney cancer	7.15e-06	5.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APC—kidney cancer	7.15e-06	5.98e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MAPK1—kidney cancer	7.12e-06	5.96e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MAPK3—kidney cancer	6.84e-06	5.73e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PIK3CA—kidney cancer	6.8e-06	5.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—POMC—kidney cancer	6.8e-06	5.69e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—KRAS—kidney cancer	6.72e-06	5.63e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—BRAF—kidney cancer	6.72e-06	5.62e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MAPK1—kidney cancer	6.51e-06	5.45e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—kidney cancer	6.49e-06	5.43e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PIK3CA—kidney cancer	6.18e-06	5.17e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—KRAS—kidney cancer	6.15e-06	5.15e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RAF1—kidney cancer	6.13e-06	5.13e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RELA—kidney cancer	6.1e-06	5.11e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ERBB2—kidney cancer	6.07e-06	5.08e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MTOR—kidney cancer	5.99e-06	5.01e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTEN—kidney cancer	5.66e-06	4.73e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PIK3CA—kidney cancer	5.65e-06	4.73e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CDKN1B—kidney cancer	5.62e-06	4.7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RAF1—kidney cancer	5.61e-06	4.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RELA—kidney cancer	5.58e-06	4.67e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ERBB2—kidney cancer	5.55e-06	4.64e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL2—kidney cancer	5.5e-06	4.6e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MTOR—kidney cancer	5.47e-06	4.58e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCND1—kidney cancer	5.36e-06	4.48e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—JUN—kidney cancer	5.35e-06	4.48e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CTNNB1—kidney cancer	5.31e-06	4.44e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTEN—kidney cancer	5.17e-06	4.33e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CDKN1B—kidney cancer	5.14e-06	4.3e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL2—kidney cancer	5.03e-06	4.21e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCND1—kidney cancer	4.9e-06	4.1e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—JUN—kidney cancer	4.89e-06	4.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CTNNB1—kidney cancer	4.85e-06	4.06e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTEN—kidney cancer	4.73e-06	3.96e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—kidney cancer	4.67e-06	3.91e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAPK3—kidney cancer	4.42e-06	3.7e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MYC—kidney cancer	4.3e-06	3.6e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—kidney cancer	4.27e-06	3.58e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAPK1—kidney cancer	4.21e-06	3.52e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAPK3—kidney cancer	4.04e-06	3.38e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3CA—kidney cancer	3.99e-06	3.34e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KRAS—kidney cancer	3.97e-06	3.32e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MYC—kidney cancer	3.93e-06	3.29e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAPK1—kidney cancer	3.85e-06	3.22e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PIK3CA—kidney cancer	3.65e-06	3.05e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KRAS—kidney cancer	3.63e-06	3.04e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—kidney cancer	3.53e-06	2.95e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PIK3CA—kidney cancer	3.34e-06	2.79e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—kidney cancer	3.23e-06	2.7e-05	CbGpPWpGaD
